首页> 外文会议>Conference on image perception, observer performance, and technology assessment >Convolutional Neural Networks for Prostate Cancer Recurrence Prediction
【24h】

Convolutional Neural Networks for Prostate Cancer Recurrence Prediction

机译:卷积神经网络用于前列腺癌复发预测

获取原文

摘要

Accurate prediction of the treatment outcome is important for cancer treatment planning. We present an approach to predict prostate cancer (PCa) recurrence after radical prostatectomy using tissue images. We used a cohort whose case vs. control (recurrent vs. non-recurrent) status had been determined using post-treatment follow up. Further, to aid the development of novel biomarkers of PCa recurrence, cases and controls were paired based on matching of other predictive clinical variables such as Gleason grade, stage, age, and race. For this cohort, tissue resection microarray with up to four cores per patient was available. The proposed approach is based on deep learning, and its novelty lies in the use of two separate convolutional neural networks (CNNs) - one to detect individual nuclei even in the crowded areas, and the other to classify them. To detect nuclear centers in an image, the first CNN predicts distance transform of the underlying (but unknown) multi-nuclear map from the input H&E image. The second CNN classifies the patches centered at nuclear centers into those belonging to cases or controls. Voting across patches extracted from image(s) of a patient yields the probability of recurrence for the patient. The proposed approach gave 0.81 AUC for a sample of 30 recurrent cases and 30 non-recurrent controls, after being trained on an independent set of 80 case-controls pairs. If validated further, such an approach might help in choosing between a combination of treatment options such as active surveillance, radical prostatectomy, radiation, and hormone therapy. It can also generalize to the prediction of treatment outcomes in other cancers.
机译:对治疗结果的准确预测对于癌症治疗计划很重要。我们提出了一种使用组织图像来预测根治性前列腺切除术后前列腺癌(PCa)复发的方法。我们使用了一个队列,其病例与对照(复发与非复发)状态已通过治疗后随访确定。此外,为了帮助开发PCa复发的新型生物标志物,根据其他预测性临床变量(例如格里森分级,阶段,年龄和种族)的匹配情况,对病例和对照进行配对。对于这个队列,每个患者最多可以使用四个核心的组织切除微阵列。所提出的方法基于深度学习,其新颖性在于使用两个单独的卷积神经网络(CNN)-一个即使在拥挤的区域也可以检测单个核,另一个可以对它们进行分类。为了检测图像中的核中心,第一个CNN会根据输入的H&E图像预测基础(但未知)多核图的距离变换。第二个CNN将以核中心为中心的补丁分类为属于案例或控制的补丁。对从患者图像中提取的补丁进行投票会产生患者复发的可能性。在对一组独立的80个病例对照对进行训练后,该方法对30个复发病例和30个非复发对照的样本给出了0.81 AUC。如果得到进一步验证,这种方法可能有助于选择治疗方案的组合,例如主动监测,根治性前列腺切除术,放射线和激素疗法。它也可以推广到其他癌症治疗结果的预测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号